Scott Lain, Healthcare Consultant, Milliman
By Evan Francis, Kelley Undergraduate Entrepreneurship & Corporate Innovation & College of Arts & Sciences Pre-Medical Sciences, Indiana University, Class of 2025
On Friday, February 16th, I had the opportunity to dive deep into the nuances of the Life Science’s Industry Impact of the Inflation Reduction Act, and let me tell you, it was an enlightening journey! 💡💼
Learning about the broad consequences of this act and how it intertwines every aspect of the life sciences industry has given me valuable insights into how policy decisions can have many adverse impacts while attempting to be beneficial to all parties involved. ✍
Moderator: David Shenberger, Vice President, Strategic Development, CAI; Diane Hilligoss, Associate Vice President and Assistant General Counsel for Value and Access, Eli Lily & Company; Scott Ford, Healthcare Tax Practice Leader/Partner, Crowe LLP; Lisa Joldersma, Founder and President, Birch Point Strategies; Barrett Tenbarge, General Counsel for Ranking Member Cassidy, Senate Health, Education, Labor and Pension Committee
Christina Fugate, Angela Rinehart, and Matt Kelly of Ice Miller LLP
Growing my understanding of this current bill and how it impacts customers, insurance providers, pharmaceutical companies, as well as their entire supply chain was a riveting experience.
Thanks so much to Indiana University and The Business of Life Sciences Program here for allowing students with an interest to dive deep int these industries prior to graduation! Especially grateful to all the different panelists with their differentiated experiences and breadth of knowledge regarding this topic taking time out of their Friday to pour into us students as well as other professionals.
I’m truly grateful for the chance to cultivate extensive knowledge about this industry and look forward to applying these insights towards my future career within the Life Sciences field. 🔬
Bill Nihill, Director – U.S. Market Access Pipeline Strategy, AbbVie; Alex Wolfe, Sr. Director – Government Strategy and Analytics, Eli Lilly & Company; Abigail Lore, Director of Innovation Policy, PhRMA; Leigh Purvis, Prescription Drug Policy Principal, Public Policy Institute, AARP; Brian Tabor, President, Indiana Hospital Association
Special thanks to all who make all these amazing conferences/events happen! Here’s to continuous learning and growth!
Audience enjoying the discussion.
Presentations
Luncheon Keynote: Legal Challenges to the Bill – Christina Fugate, Angela Rinehart and Matt Kelly, Ice Miller LLP
Panel: Effects on Industry Segments
Brian Tabor, Indiana Hospital Association
Thanks so much to all the corporate partners and those involved to plan this event!
Leave a Reply